Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | SRC | P12931 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 3/20 | 0.42 |
| ▸ | LIG1 | P18858 | 1/20 | 0.41 |
| ▸ | RHOA | P61586 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2879781 | 0.93 | CYP3A4 (0.56) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL10646849 | 0.90 | CYP3A4 (0.53) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL9230354 | 0.85 | CYP3A4 (0.55) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL7878160 | 0.84 | CYP3A4 (0.53) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL6681237 | 0.84 | CYP3A4 (0.53) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL6681242 | 0.84 | CYP3A4 (0.53) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL10676559 | 0.82 | CYP3A4 (0.51) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL10590388 | 0.82 | CYP3A4 (0.51) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL5994364 | 0.82 | CYP3A4 (0.51) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 | |
| SCHEMBL5325702 | 0.82 | CYP3A4 (0.51) | CYP3A4ALDH1A1TSHRHSD17B10CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7153860-B2 | 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-26 | — | — | US | claimed |
| US-20040116429-A1 | 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | BASF SE (DE) | 2004-06-17 | — | — | US | claimed |
| US-20230159678-A1 | METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS | NATIONAL SCIENCE FOUNDATION | 2023-05-25 | — | — | US | disclosed |
| US-20230159678-A1 | METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS | NATIONAL SCIENCE FOUNDATION | 2023-05-25 | — | — | US | disclosed |
| US-20220315706-A1 | PHOTOPOLYMERIZABLE THERMOPLASTICS AND METHODS OF MAKING AND USING SAME | UNIV COLORADO REGENTS (US) | 2022-10-06 | — | — | US | disclosed |
| WO-2022133280-A1 | COMPOSITION FOR REVERSIBLE POLYMERIZATION OF THIOESTER AND METHODS THEREOF | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2021257692-A1 | METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2021-12-23 | — | — | WO | disclosed |
| WO-2020247928-A1 | PHOTOPOLYMERIZABLE THERMOPLASTICS AND METHODS OF MAKING AND USING SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2020-12-10 | — | — | WO | disclosed |
| US-10424812-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20170200976-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-07-13 | — | — | US | disclosed |
| US-20170200976-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-07-13 | — | — | US | disclosed |
| CN-105026444-A | Curable composition, transparent heat-resistant material, and use thereof | SHOWA DENKO KK | 2015-11-04 | — | — | CN | disclosed |
| US-7709637-B2 | 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi | BASF SE (DE) | 2010-05-04 | — | — | US | disclosed |
| US-20070088026-A1 | 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi | METAVANTE CORPORATION | 2007-04-19 | — | — | US | disclosed |
| US-7153860-B2 | 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-26 | — | — | US | disclosed |
| US-20040116429-A1 | 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | BASF SE (DE) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088026-A1 | 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi | DPYD, CBR3, RNGTT | CYP3A4 169/4885ALDH1A1 775/4885TSHR 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.